Study of a New Medical Device for Oral Mucositis
NCT: NCT05104268 · WITHDRAWN
広告
NCT識別子NCT05104268
ステータスWITHDRAWN
開始日2024-11-30
完了2025-12-31
SponsorE2Bio Life Sciences, LLC (INDUSTRY)
First posted
Last updated
概要
This is a single-center randomized controlled trial of a new medical device (Bocaliner™) that has been designed to improve the treatment of chemotherapy-induced oral mucositis in patients undergoing cancer treatment. The goal of this study is to determine tolerance and response to the use of Bocaliner™ as reported by patients with chemotherapy and/or radiation therapy-induced oral mucositis.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。